These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 17094589)

  • 1. [Preparation and characterization of monoclonal antibody specific to PfCP-2.9 chimeric protein of Plasmodium falciparum].
    Wang R; Qian F; Qu L; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Aug; 24(4):247-50. PubMed ID: 17094589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.
    Li C; Wang R; Wu Y; Zhang D; He Z; Pan W
    Malar J; 2010 Apr; 9():94. PubMed ID: 20384992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro.
    Pan W; Huang D; Zhang Q; Qu L; Zhang D; Zhang X; Xue X; Qian F
    J Immunol; 2004 May; 172(10):6167-74. PubMed ID: 15128804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
    Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
    Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant.
    Xue X; Ding F; Zhang Q; Pan X; Qu L; Pan W
    Vaccine; 2010 Apr; 28(18):3152-8. PubMed ID: 20197139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites.
    Zhang D; Pan W
    Infect Immun; 2005 Oct; 73(10):6530-6. PubMed ID: 16177327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria.
    Peng H; Hu Y; Zhou A; Jin C; Pan W
    Malar J; 2010 Mar; 9():76. PubMed ID: 20236549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant multi-epitope, multi-stage malaria vaccine candidate expressed in Escherichia coli.
    Li M; Bi H; Dong W; Xu W; Li Q; Li Y
    Chin Med J (Engl); 1999 Aug; 112(8):691-7. PubMed ID: 11601273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and characterization of monoclonal antibodies against erythrocyte-binding antigen 175 of Plasmodium falciparum].
    Hao WB; Hong YH; Sun XM; Ning Y; Zhang DM; Pan WQ; Li M
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1169-71. PubMed ID: 16174591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective antibody response to recombinant fragments of Plasmodium falciparum apical membrane antigen 1].
    Li X; Xue CF; Liu ZX; Wang XF; Ding J; Lei JC; Zhen RF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(2):80-3. PubMed ID: 12884614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro detection of immune sera to Plasmodium falciparum chimeric protein-2.9 for inhibition of parasite growth by LDH method].
    Qu L; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Jun; 24(3):223-5. PubMed ID: 17094629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of monoclonal antibodies specific to lactate dehydrogenase of Plasmodium falciparum].
    Wang JY; Bao YF; Yang YT; Tang LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Aug; 23(4):213-6. PubMed ID: 16296608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of monoclonal antibodies against the adhesion protein 33 of Trichomonas vaginalis].
    Huang HC; Yu SF; Cai M; Tan F; Zheng XY; Pan CW
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Apr; 25(2):97-100, 105. PubMed ID: 17633817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of deleting 9 amino acid residues at N-terminus on immunogenicity of a Plasmodium falciparum chimeric protein].
    Zhang QF; Pan WQ; Qu L; Xue XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):345-9. PubMed ID: 12673388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
    Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
    Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes.
    Chappel JA; Hollingdale MR; Kang AS
    Hum Antibodies; 2004; 13(3):91-6. PubMed ID: 15598989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of monoclonal antibody against Pfs25 protein and establishment of double antibody sandwich ELISA method].
    Li P; Ma YR; Lu J; Lei Q; Chen Y; Jiang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Dec; 27(12):1330-4. PubMed ID: 22152818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of immunogenicity and protection efficacy of the recombinant hypoxanthine-guanine-xanthine of plasmodium falciparum in mice].
    Xiao JY; Zhang DM; Cai LS; Shen LH; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Jun; 24(3):192-5. PubMed ID: 17094620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.